Viewing Study NCT00681720


Ignite Creation Date: 2025-12-25 @ 4:13 AM
Ignite Modification Date: 2026-01-09 @ 7:51 PM
Study NCT ID: NCT00681720
Status: COMPLETED
Last Update Posted: 2008-08-21
First Post: 2008-05-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Positron Emission Tomography (PET) Study With (11C)Flumazenil to Determine Central GABAA Receptor Occupancy of AZD7325
Sponsor: AstraZeneca
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: D1140C00007
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Mark A. Smith, MD, Medical Science Director, Emerging Psychiatry
Old Organization: AstraZeneca

Collaborators